Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL8850278 | 0.98 | CA2 (0.47) | CA2MAPK1ALDH1A1RNPEPTSHR | |
| SCHEMBL211376 | 0.96 | CA2 (0.46) | CA2MAPK1ALDH1A1RNPEPTSHR | |
| SCHEMBL28958204 | 0.95 | CA2 (0.44) | CA2MAPK1ALDH1A1RNPEPTSHR | |
| Phosphoric Acid SCHEMBL4891228 | 0.93 | CA2 (0.43) | CA2MAPK1ALDH1A1RNPEPTSHR | |
| SCHEMBL6361967 | 0.92 | CA2 (0.42) | CA2MAPK1ALDH1A1RNPEPTSHR | |
| SCHEMBL5324009 | 0.89 | CA2 (0.40) | CA2MAPK1ALDH1A1RNPEPTSHR | |
| SCHEMBL8931815 | 0.89 | CA2 (0.40) | CA2MAPK1ALDH1A1RNPEPTSHR | |
| SCHEMBL8931819 | 0.86 | GMNN (0.39) | CA2MAPK1ALDH1A1RNPEPTSHR | |
| SCHEMBL29133312 | 0.85 | CA2 (0.47) | CA2MAPK1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL9242496 | 0.85 | CA2 (0.52) | CA2MAPK1ALDH1A1RNPEPTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 924 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3685231-B1 | 3D PRINTING WITH POLYMERIC NANOGEL PARTICLES | THE REGENTS OF THE UNIV OF COLORADO A BODY CORPORATE A COLORADO NON PROFIT (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4247859-B1 | POWDER COMPOSITION OF MULTILAYER POLYMER AND OLIGOMERIC COAGULATION AND DISPERSION AID | ROHM & HAAS (US) | 2026-03-25 | — | — | EP | claimed |
| US-20260071133-A1 | HYDRAULIC LUBRICANT FORMULATIONS WITH HIGH FLASH POINT AND IMPROVED SHEAR STABILITY | EVONIK OPERATIONS GMBH (DE) | 2026-03-12 | — | — | US | claimed |
| EP-4448702-B1 | HYDRAULIC LUBRICANT FORMULATIONS WITH HIGH FLASH POINT AND IMPROVED SHEAR STABILITY | EVONIK OPERATIONS GMBH (DE) | 2026-02-04 | — | — | EP | claimed |
| US-12365702-B2 | Process for the production of alkyltin halides | GALATA CHEMICALS LLC (US) | 2025-07-22 | — | — | US | claimed |
| US-12252661-B2 | Process for preparing homo- and copolymers of alkyl (meth)acrylates with low residual monomer content | EVONIK OPERATIONS GMBH (DE) | 2025-03-18 | — | — | US | claimed |
| US-20240417643-A1 | HYDRAULIC LUBRICANT FORMULATIONS WITH HIGH FLASH POINT AND IMPROVED SHEAR STABILITY | EVONIK OPERATIONS GMBH (DE) | 2024-12-19 | — | — | US | claimed |
| EP-3475323-B1 | CONTROL OF POLYMER NETWORK STRUCTURES VIA NANOGELS | UNIV COLORADO REGENTS (US) | 2024-12-11 | — | — | EP | claimed |
| EP-4448702-A1 | HYDRAULIC LUBRICANT FORMULATIONS WITH HIGH FLASH POINT AND IMPROVED SHEAR STABILITY | Evonik Operations GmbH (DE) | 2024-10-23 | — | — | EP | claimed |
| EP-4265656-B1 | POLYMER LATEX FOR WOOD ADHESIVES | SYNTHOMER DEUTSCHLAND GMBH (DE) | 2024-09-18 | — | — | EP | claimed |
| US-20040230019-A1 | Solution polymerization, coagulation, filtering, drying; synergistic blends with excellent mechanical properties; automotive parts and electronic connectors | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-11-18 | — | — | US | claimed |
| EP-1448635-A2 | GRAFT COPOLYMERS OF METHYLENE LACTONES AND PROCESS FOR EMULSION POLYMERIZATION OF METHYLENE LACTONES | E. I. du Pont de Nemours and Company (US) | 2004-08-25 | — | — | EP | claimed |
| WO-2004069926-A1 | POLY(ALPHA-METHYLENE-GAMMA-METHYL-GAMMA-BUTYROLACTONE- CO-GLYCIDYL METHACRYLATE): PREPARATION, POLYMER BLENDS DERIVED THEREFROM, AND END USES THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-08-19 | — | — | WO | claimed |
| WO-2004069925-A1 | BLENDS OF POLY(ALPHA-METHYLENE-GAMMA- METHYL-GAMMA-BUTYROLACTONE-co-GLYCIDYL METHACRYLATE) AND POLYPHENYLENE SULFIDE POLYMER, ARTICLES THEREFROM AND PREPARATION THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-08-19 | — | — | WO | claimed |
| US-20030171522-A1 | Graft copolymers of methylene lactones and process for emulsion polymerization of methylene lactones | E.I. DU PONT DE NEMOURS AND COMPANY | 2003-09-11 | — | — | US | claimed |
| WO-2003048220-A2 | GRAFT COPOLYMERS OF METHYLENE LACTONES AND PROCESS FOR EMULSION POLYMERIZATION OF METHYLENE LACTONES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-06-12 | — | — | WO | claimed |
| EP-0538673-B1 | Clear, vapour-sterilisable, non-zytotoxic, essentially compact polyurethane casting compounds, process for their preparation and their use, especially for medical-technical articles | BASF AG (DE) | 1998-01-07 | — | — | EP | claimed |
| EP-0357295-B1 | Catalysts for hydrotreating of hydrocarbons and methods of preparing the same | SUMITOMO METAL MINING CO (JP) | 1996-07-03 | — | — | EP | claimed |
| EP-0289211-B1 | CATALYSTS FOR HYDROTREATING HYDROCARBONS AND METHOD OF ACTIVATING THE SAME | SUMITOMO METAL MINING COMPANY LIMITED (JP) | 1993-09-29 | — | — | EP | claimed |
| US-4910274-A | Free radical catalyst, chain transfer agent | THE DOW CHEMICAL COMPANY (US) | 1990-03-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071133-A1 | HYDRAULIC LUBRICANT FORMULATIONS WITH HIGH FLASH POINT AND IMPROVED SHEAR STABILITY | F5, FGB, MST1 | CA2 3907/4885MAPK1 1064/4885ALDH1A1 3064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.